Thymus Transplantation Safety-Efficacy
Not Applicable
Completed
- Conditions
- Complete DiGeorge AnomalyDiGeorge SyndromeDiGeorge AnomalyComplete DiGeorge Syndrome
- Interventions
- First Posted Date
- 2010-10-14
- Last Posted Date
- 2025-01-16
- Lead Sponsor
- Sumitomo Pharma Switzerland GmbH
- Target Recruit Count
- 29
- Registration Number
- NCT01220531
- Locations
- 🇺🇸
John W. Sleasman, Durham, North Carolina, United States
Serum-Free Thymus Transplantation in DiGeorge Anomaly
Phase 1
Terminated
- Conditions
- DiGeorge Anomaly
- Interventions
- Biological: Serum Free Thymus Transplantation with ImmunosuppressionOther: Serum Free Thymus Transplantation without immunosuppression
- First Posted Date
- 2009-02-24
- Last Posted Date
- 2022-04-01
- Lead Sponsor
- Sumitomo Pharma Switzerland GmbH
- Target Recruit Count
- 2
- Registration Number
- NCT00849888
Phase I Study of Umbilical Cord Blood Transplantation Followed by Third Party Thymus Transplantation
Phase 1
Terminated
- Conditions
- Stem Cell Transplantation
- Interventions
- Biological: Thymic Transplantation for Recipients of UCB transplant
- First Posted Date
- 2008-01-18
- Last Posted Date
- 2022-04-01
- Lead Sponsor
- Sumitomo Pharma Switzerland GmbH
- Target Recruit Count
- 6
- Registration Number
- NCT00597441
- Locations
- 🇺🇸
Duke University Health System, Durham, North Carolina, United States
Thymus Transplantation With Immunosuppression
Phase 1
Completed
- Conditions
- DiGeorge AnomalyDiGeorge SyndromeComplete DiGeorge AnomalyComplete DiGeorge Syndrome
- Interventions
- Biological: Thymus Tissue for Transplantation
- First Posted Date
- 2007-12-24
- Last Posted Date
- 2022-04-04
- Lead Sponsor
- Sumitomo Pharma Switzerland GmbH
- Target Recruit Count
- 15
- Registration Number
- NCT00579709
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
Phase I/II Thymus Transplantation With Immunosuppression #950
Phase 1
Completed
- Conditions
- Complete Atypical DiGeorge SyndromeDiGeorge AnomalyComplete Atypical DiGeorge AnomalyComplete DiGeorge SyndromeComplete DiGeorge Anomaly
- Interventions
- Biological: Cultured Thymus Tissue for Implantation (CTTI)Other: Cultured Thymus Tissue Implantation and Parental Parathyroid TransplantationProcedure: Blood Draw
- First Posted Date
- 2007-12-24
- Last Posted Date
- 2022-03-25
- Lead Sponsor
- Sumitomo Pharma Switzerland GmbH
- Target Recruit Count
- 14
- Registration Number
- NCT00579527
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
Thymus Transplantation in DiGeorge Syndrome #668
Phase 2
Completed
- Conditions
- DiGeorge SyndromeComplete Typical DiGeorge Anomaly
- Interventions
- Biological: Cultured Thymus Tissue for Implantation (CTTI)
- First Posted Date
- 2007-12-19
- Last Posted Date
- 2022-03-25
- Lead Sponsor
- Sumitomo Pharma Switzerland GmbH
- Target Recruit Count
- 26
- Registration Number
- NCT00576407
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
Thymus Transplantation Dose in DiGeorge #932
Phase 2
Completed
- Conditions
- DiGeorge AnomalyComplete DiGeorge AnomalyDiGeorge SyndromeComplete DiGeorge Syndrome
- Interventions
- Other: Cultured Thymus Tissue Implantation with Parathyroid TransplantationBiological: Cultured Thymus Tissue Implantation (CTTI)
- First Posted Date
- 2007-12-19
- Last Posted Date
- 2022-03-25
- Lead Sponsor
- Sumitomo Pharma Switzerland GmbH
- Target Recruit Count
- 7
- Registration Number
- NCT00576836
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
Parathyroid and Thymus Transplantation in DiGeorge #931
Phase 1
Completed
- Conditions
- DiGeorge SyndromeHypoparathyroidismComplete DiGeorge Syndrome
- Interventions
- Biological: Thymus/Parathyroid Transplantation
- First Posted Date
- 2007-12-03
- Last Posted Date
- 2022-04-04
- Lead Sponsor
- Sumitomo Pharma Switzerland GmbH
- Target Recruit Count
- 25
- Registration Number
- NCT00566488
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
© Copyright 2025. All Rights Reserved by MedPath